Advertisement

Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 1341 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Congenica–Science Foundation Ireland: bioinformatics, 201802– collab developm diagnosis of genetic epilepsy using Sapientia s/w with FutureNeuro 2018-02-12
Nosopharm–Andrew Lloyd Associates: public relations, 201802 service existent by ALA 2018-02-12
Impact Biomedicines–Medicxi Ventures: investment, 201801 existent investor 2018-02-07
LCF Rothschild–SEVERAL: investment, 201802 closing €345m of BioDiscovery 5 fund of EdRIP 2018-02-07
Faron Pharmaceuticals–Lyomark Pharma: Traumakine, 201802– supply contract manfucturing by Lyocontract GmbH 2018-02-05
Faron Pharmaceuticals–Rentschler: Traumakine, 201802 supply existent contract manfucturing by Rentschler Biopharma SE 2018-02-05
Faron Pharmaceuticals–Westwicke Partners: public relations, 201802 service existent US IR by Westwicke Partners 2018-02-05
LIG Biowise–Phoenix Bridge (HK): investment, 201802 financing round Series A totalling £1.8m incl lead investor Phoenix Bridge 2018-02-05
LIG Biowise–SEVERAL: investment, 201802 financing round Series A £1.8m led by Phoenix Bridge (HK) 2018-02-05
Syndesi Therapeutics–SEVERAL: investment, 201802 financing round Series A €17m co-led by Novo Seeds + Fountain Healthcare 2018-02-01
Evonetix–SEVERAL: investment, 201801 financing round Serise A £9m ($12.3m) co-led by DVCV + Draper Esprit 2018-01-30
Evonetix–Zyme Communications: public relations, 201801 service existent by Zyme 2018-01-30
Foundry Innovation & Research 1–SEVERAL: investment, 201801 financing round Series C €40m of FIRE1 led by new investor Gilde Healthcare 2018-01-30
Concept Life Sciences–Spectris: investment, 201801 acquisition £163m on debt/cash-free basis from Equistone Partners + company management 2018-01-26
ImmuPharma–SEVERAL: investment, 201801 placing £10m of 6.945m new ordinary shares at 144p/share 2018-01-24
Almac–Salesforce.com: CRM software, 201801– supply Almac Clinical Technology implements Salesforce Service Cloud 2018-01-23
Concept Life Sciences–Alderley Analytical: analytical services, 201801– collab partnership to provide bioanalytical + DMPK services 2018-01-18
Adverum Biotechnologies–Synpromics: genomic technology, 201801 collab existent 2018-01-17
BIA Separations–Zyme Communications: public relations, 201801 service existent by Zyme 2018-01-17
BioMarin–Synpromics: genomic technology, 201801 collab existent 2018-01-17
General Electric–Synpromics: genomic technology, 201801 collab existent with GE Healthcare 2018-01-17
Homology Medicines–Synpromics: genomic technology, 201801 collab existent 2018-01-17
Sartorius–Synpromics: genomic technology, 201801 collab existent with Sartorius Stedim Cellca 2018-01-17
Synpromics–Sciad Communications: public relations, 201801 service existent by Sciad 2018-01-17
Uniqure–Synpromics: genomic technology, 201801 collab existent 2018-01-17
Metrion Biosciences–SEVERAL: investment, 201801– crowd funding targeting £600k via SyndicateRoom 2018-01-16
Waters–Spectris: analytical instruments, 201801– collab co-marketing agreem with Malvern Panalytical for Omnisec Reveal with Acquity APC system 2018-01-16
e-Therapeutics–Biorelate: drug discovery software, 201801– collab €na using AI to improve computational drug discovery technology 2018-01-15
e-Therapeutics–Intellegens: drug discovery software, 201801– collab €na using AI to improve computational drug discovery technology 2018-01-15
Vaccitech–SEVERAL: investment, 201801 financing round Series A £20m with GV + Sequoia China + OSI + Neptune Ventures 2018-01-15
CombiGene–United Kingdom (govt): gene therapy manufacturing, 201801– collab developm manufacturing processes for CG01 with CGT Catapult 2018-01-12
Intelligent Pharma–Mind the Byte: investment, 201801 acquisition €na 100% of Intelligent Pharma by Mind the Byte 2018-01-11
KWS Biotest–Charles River: investment, 201801 acquisition of KWS Biotest Ltd for £15m cash + £3m milestones 2018-01-11
Mind the Byte–SEVERAL: investment, 201801– financing round €3m (1/3 of company) to finance acquisition of Intelligent Pharma PLANNED 2018-01-11
Sosei–Imperial College: drug discovery, 201801– collab r+d focused on GPCR disease targets in gastro-interstinal tract Heptares 2018-01-10
Structural Genomics Consortium–Enamine: chemical compound libraries, 201801– supply new generation of Diamond-SGC-iNEXT (DSI) Poised Library 2018-01-10
BioNTech–Scancell: cancer immunotherapy, 201801– collab research using Moditope platform w excl license option for BioNTech 2018-01-09
F-Star–Instinctif Partners: public relations, 201801 service existent by Instinctif for EU + RoW 2018-01-09
F-Star–Lazar Partners: public relations, 201801 service existent by Lazar Partners for US 2018-01-09
Luxcel Biosciences–Agilent: investment, 201801 acquisition €na of Luxcel by Agilent 2018-01-09
Orchard Therapeutics–JPMorgan Chase: investor conference, 201801 supply service Orchard presents at JP Morgan Healthcare Conference 2018 2018-01-09
General Electric–Roche: diagnostics, 201801– collab developm integrated digital + IVD + in vivo diagnostics platform for oncology + critical care 2018-01-08
Hookipa Biotech–JPMorgan Chase: investor conference, 201801 supply service Hookipa presents at JP Morgan Healthcare Conference 2018 2018-01-08
Mallinckrodt–JPMorgan Chase: investor conference, 201801 supply service Mallinckrodt presents at JP Morgan Healthcare Conference 2018 2018-01-08
Storm Therapeutics–Optimum Strategic Communications: public relations, 201801 service existent by Optimum 2018-01-08
Storm Therapeutics–Otsuka: investment, 201801 investment £4m by Taiho Ventures LLC extends Series A round to £16m 2018-01-08
United Kingdom (govt)–Edico Genome: bioinformatics, 201801– supply + collab Genomics England to adopt DRAGEN platform for sequending data analysis 2018-01-08
Adaptimmune–Hitachi: cell therapy manufacturing, 201801 existent manufacturing of SPEAR-T cells by PCT 2018-01-05
Adaptimmune–United Kingdom (govt): cell therapy manufacturing, 201801– dedicated vector mftg space at CGT Catapult Manufacturing Centre 2018-01-05
Takeda–Denali Therapeutics: neurological drugs, 201801– collab + option agreem for 3 drug candidates for neurodegenerative diseases 2018-01-05
Indivior–Addex: ADX71441, 201801– license + collab agreem $5m upfront + $4m research funding + $330m milestones plus royalties 2018-01-03
Sucampo–Mallinckrodt: investment, 201712– acquisition $1.2b cash tender offer at $18/share ANNOUNCED 2017-12-26
Orchard Therapeutics–LifeSci: public relations, 201712 service existent by LifeSci Public Relations 2017-12-22
Orchard Therapeutics–SEVERAL: investment, 201712 financing round Series B £85m co-led by Baillie Gifford + ORI Capital 2017-12-20
Autifony–Instinctif Partners: public relations, 201712 service existent by Instinctif 2017-12-18
Boehringer–Autifony: CNS drugs, 201712– collab €25m upfront + up to total of €627.5m excl option to acquire KV3.1/3.2 positive modulators for BI 2017-12-18
Roche–Horizon Discovery: reference standards, 201712– collab developm + supply of FFPE reference standards for ICH-NTRK assays for Roche Dx 2017-12-18
Ablynx–Leucadia: investor conference, 201711 supply service Ablynx presents at Annual Jefferies Healthcare Conference London 2017-12-16
BPCE–Instinctif Partners: public relations, 201712 service existent for Seventure Partners by Instinctif Partners 2017-12-14
Life Sciences Partners–Optimum Strategic Communications: public relations, 201712 service existent by Optimum 2017-12-12
NorthSea Therapeutics–Instinctif Partners: public relations, 201712 service existent by Instinctif Partners 2017-12-12
ProImmune–Zyme Communications: public relations, 201712 service existent by Zyme 2017-12-12
PGS.Holland–bio.logis: genetic software, 201712– distribution of bio.logis GIMS in Benelux + Scandinavia + UK by PGS.Holland BV 2017-12-08
Bluebird Bio–TC BioPharm: T cell therapy, 201712– collab r+d $16m upfront + milestones + royalties CAR-engineered gamma delta T cells for cancer 2017-12-07
Cell Medica–Coulter Partners: recruitment services, 201712 supply service placement of Annalisa Jenkins as new Board Chair of Cell Medica 2017-12-07
Charles River–ERS Genomics: CRISPR technology, 201712– license €na ww non-excl for CRISPR-Cas9 technology to generate modified cell lines 2017-12-06
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Advicenne–Huntsworth: public relations, 201712 service existent by Citigate Dewe Rogerson 2017-12-05
Horizon Discovery–ERS Genomics: CRISPR technology, 201712– license ww non-excl expansion 2017-12-05
Probiodrug–Optimum Strategic Communications: public relations, 201712 service existent by Optimum 2017-12-05
Arrowhead–Silence Therapeutics: investment, 201712 DIVESTMENT 2.036m common shares for $7.5m w realised profit of $4.1m 2017-12-04
CLINGLIO project–EU (govt): grant, 201712–202011 Horizon 2020 grant €6.15m 3y for ph2 trial of 2OHOA in malignant glioma 2017-12-01
Irish Stock Exchange–Euronext: investment, 201711– acquisition €173m debt/cash free ANNOUNCED 2017-11-29
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
Geneva Biotech–Sphere Fluidics: genomic technology, 201711– collab to develop large DNA cargo gene deliver + genome engineering systems 2017-11-27
GSK–Owlstone: breath analyser, 201711– collab Breath Biopsy platform used in ph2 respiratory disease study of danirixin 2017-11-27
Microbiotica–Instinctif Partners: public relations, 201711 service existent by Instinctif Partners 2017-11-27
Sphere Fluidics–Zyme Communications: public relations, 201711 service existent by Zyme 2017-11-27
LabGenius–SEVERAL: investment, 201711 seed financing round $3.66m co-led by Kindred Capital + Acequia Capital 2017-11-24
Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm 2017-11-22
Cosmo Pharmaceuticals–Leucadia: investor conference, 201711 supply service Cosmo attends Jefferies London Healthcare Conference 2017-11-16
Elpis BioMed–SEVERAL: investment, 201711 seed financing round led by Jonathan Milner + incl D Disley + W Janeway + N Starzacher 2017-11-16
Elpis BioMed–Zyme Communications: public relations, 201711 service existent by Zyme 2017-11-16
Twist Bioscience–Oxford Genetics: nucleic acid expression technology, 201711– license to SnapFast expression vectors to Twist Bioscience 2017-11-16
Affimed–Leucadia: investor conference, 201711 supply service Affimed presents at Jefferies 2017 London Healthcare Conference 2017-11-15
Calliditas Therapeutics–Optimum Strategic Communications: public relations, 201711 service existent by Optimum 2017-11-15
Erytech–Leucadia: investor conference, 201711 supply service Erytech at Jefferies London Healthcare Conference 2017 2017-11-15
Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London 2017-11-15
TxCell–Leucadia: investor conference, 201711 supply service TxCell attends Jefferies London Healthcare Conference 2017 2017-11-15
Biocartis–TopBio1: investment, 201711 DIVESTMENT off all shares (above 3% before) by TopBio1 LP 2017-11-14
Pharmaceuticals International–Quotient: investment, 201711 acquisition of Pharmaterials Ltd by Quotient Sciences Ltd 2017-11-14
Quotient–Zyme Communications: public relations, 201711 service existent by Zyme 2017-11-10
Boehringer–MiNA Therapeutics: RNAa drugs, 201711– collab up to €307m plus royalties developm of RNAa drugs for fibrotic liver diseases incl NASH 2017-11-08
MiNA Therapeutics–MacDougall Biomedical Communications: public relations, 201711 service existent by MacDougall 2017-11-08
Fortuna Fix–SEVERAL: investment, 201711 financing round Series B £18.75m 2017-11-06
NousCom–5AM Ventures: investment, 201711 financing round Series B totalling €42m incl new + co-investor 5AM Ventures 2017-11-06
NousCom–Abingworth: investment, 201711 financing round Series B totalling €42m incl new + lead investor Abingworth 2017-11-06
NousCom–Huntsworth: public relations, 201711 service existent by Citigate Dewe Rogerson 2017-11-06
NousCom–Life Sciences Partners: investment, 201711 financing round Series B totalling €42m incl returning co-investor LSP 2017-11-06
NousCom–SEVERAL: investment, 201711 financing round Series B €42m led by new investor Abingworth + incl 5AM Ventures + LSP + Versant Ventures 2017-11-06
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Partnering Events Spring 2018 CBPF18 BES18 BEE18 600x060px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture EBD Group BIO-Europe Spring 2018 BES Amsterdam March 120x180px